Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Total
Balance at Dec. 31, 2022	$ 11	$ 2,664,730	$ (1,942,635)	$ (16,362)	$ 705,744
Balance (in shares) at Dec. 31, 2022	111,255,000
Issuance of common stock upon exercise of stock options		3,892			3,892
Issuance of common stock upon exercise of stock options (in shares)	298,000
Issuance of common stock under the employee stock purchase plan		15,128			15,128
Issuance of common stock under the employee stock purchase plan (in shares)	392,000
Issuance of common stock for IPR&D milestone		14,435			14,435
Issuance of common stock for IPR&D milestone (in shares)	336,000
Issuance of common stock for bonuses		19,774			19,774
Issuance of common stock for bonuses (in shares)	349,000
Vesting of restricted stock (in shares)	2,401,000
Stock based compensation		192,437			192,437
Unrealized gain on available-for-sale securities and foreign currency translation adjustment				13,277	13,277
Issuance of common stock for public offering, net		235,441			235,441
Issuance of common stock for public offering, net (in shares)	4,550,000
Net loss			(434,801)		(434,801)
Balance at Dec. 31, 2023	$ 11	3,145,837	(2,377,436)	(3,085)	765,327
Balance (in shares) at Dec. 31, 2023	119,581,000
Issuance of common stock upon exercise of stock options		12,988			12,988
Issuance of common stock upon exercise of stock options (in shares)	1,626,000
Issuance of common stock under the employee stock purchase plan		17,298			17,298
Issuance of common stock under the employee stock purchase plan (in shares)	369,000
Issuance of common stock for bonuses		24,071			24,071
Issuance of common stock for bonuses (in shares)	270,000
Issuance of common stock for Convertible Notes and accrued interest	$ 1	286,729			286,730
Issuance of common stock for Convertible Notes and accrued interest, (in shares)	7,532,000
Vesting of restricted stock (in shares)	3,268,000
Stock based compensation		276,691			276,691
Unrealized gain on available-for-sale securities and foreign currency translation adjustment				2,741	2,741
Net loss			(190,426)		(190,426)
Balance at Dec. 31, 2024	$ 12	3,763,614	(2,567,862)	(344)	$ 1,195,420
Balance (in shares) at Dec. 31, 2024	132,646,000				132,646,000
Issuance of common stock upon exercise of stock options		22,536			$ 22,536
Issuance of common stock upon exercise of stock options (in shares)	370,000
Issuance of common stock under the employee stock purchase plan		25,035			25,035
Issuance of common stock under the employee stock purchase plan (in shares)	216,000
Issuance of common stock for bonuses		32,875			32,875
Issuance of common stock for bonuses (in shares)	228,000
Issuance of common stock pursuant to business combination, net		287,316			287,316
Issuance of common stock pursuant to business combination, net (in shares)	1,137,000
Vesting of restricted stock	$ 2				2
Vesting of restricted stock (in shares)	5,096,000
Stock based compensation		357,303			357,303
Unrealized gain on available-for-sale securities and foreign currency translation adjustment				86	86
Net loss			(208,160)		(208,160)
Balance at Dec. 31, 2025	$ 14	$ 4,488,679	$ (2,776,022)	$ (258)	$ 1,712,413
Balance (in shares) at Dec. 31, 2025	139,693,000				139,693,000